CDNA - Caredx - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CDNA is currently covered by 8 analysts with an average price target of $22.81. This is a potential upside of $10.74 (88.98%) from yesterday's end of day stock price of $12.07.

Caredx's activity chart (see below) currently has 138 price targets and 125 ratings on display. The stock rating distribution of CDNA is 44.83% HOLD and 55.17% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 75.88% with an average time for these price targets to be met of 310.15 days.

Highest price target for CDNA is $40, Lowest price target is $24, average price target is $30.33.

Most recent stock forecast was given by MASON CARRICO from STEPHENS on 05-May-2025. First documented stock forecast 18-Mar-2015.

Currently out of the existing stock ratings of CDNA, 13 are a HOLD (44.83%), 16 are a BUY (55.17%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$40

$27.71 (225.47%)

$40

3 months 3 days ago
(05-May-2025)

6/9 (66.67%)

$24.83 (163.68%)

205

Hold

$25

$12.71 (103.42%)

$25

3 months 3 days ago
(05-May-2025)

6/9 (66.67%)

$9.83 (64.80%)

165

Buy

$26

$13.71 (111.55%)

$35

3 months 22 days ago
(17-Apr-2025)

7/10 (70%)

$8.38 (47.56%)

264

Hold

$24

$11.71 (95.28%)

$35

6 months 24 days ago
(15-Jan-2025)

2/2 (100%)

$1.3 (5.73%)

26

Buy

$35

$22.71 (184.78%)

$40

9 months 3 days ago
(05-Nov-2024)

2/7 (28.57%)

$12.1 (52.84%)

294

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CDNA (Caredx) average time for price targets to be met?

On average it took 310.15 days on average for the stock forecasts to be realized with a an average price target met ratio 75.88

Which analyst has the current highest performing score on CDNA (Caredx) with a proven track record?

WILLIAM QUIRK

Which analyst has the most public recommendations on CDNA (Caredx)?

William Quirk has 8 price targets and 5 ratings on CDNA

Which analyst is the currently most bullish on CDNA (Caredx)?

Steven Mah with highest potential upside - $97.71

Which analyst is the currently most reserved on CDNA (Caredx)?

Andrew Cooper with lowest potential downside - -$0

Caredx in the News

CareDx (CDNA) EPS Beats Sales Gain 14%

Key Points Non-GAAP earnings per share were $0.10 in Q2 2025, beating consensus estimates. Adjusted revenue rose 14%, slightly missing non-GAAP expectations but still reflecting strong testing services volume growth. Full-year 2025 revenue guidance was narrowed, with management maintaining its adjusted EBITDA outlook and reporting $186 million in cash, cash equivalents, and marketable securities and...

CareDx narrows 2025 revenue guidance to $367M-$373M as kidney surveillance protocols expand

Earnings Call Insights: CareDx, Inc (CDNA) Q2 2025 MANAGEMENT VIEW * John Walter Hanna, President and CEO, opened by highlighting CareDx’s participation at the World Transplant Congress, where the company unveiled a new brand identity and showcased over 40 abstracts and 16 oral presentations demonstrating advances in AI predictive diagnostics, transplant access, and organ-specific innovation....
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?